6-MP 50 Mg (Mercaptopurine)

6-MP 50 mg (Mercaptopurine)

6-MP 50 mg

contains mercaptopurine, a purine antagonist used in the maintenance treatment of
Acute Lymphoblastic Leukemia (ALL). It interferes with DNA and RNA synthesis to suppress
abnormal white blood cell growth.

Product Introduction

Mercaptopurine is a thiopurine antimetabolite that inhibits purine synthesis and slows the growth of
rapidly dividing leukemic cells. It is commonly used during the maintenance phase of ALL therapy,
often alongside methotrexate.

Uses of 6-MP 50 mg

• Acute Lymphoblastic Leukemia (ALL) – maintenance therapy
• Acute Myeloid Leukemia (selected protocols)
• Chronic Myelogenous Leukemia (rare or older protocols)
• Specialist-directed autoimmune use (rare)

Note: Use only within an approved oncology protocol.

Benefits

• Helps maintain long-term remission in ALL
• Oral tablet suitable for home administration
• Well-established in leukemia treatment regimens
• Dosing can be adjusted based on genetic testing

In Treatment of Worm Infections

Important: Mercaptopurine does not treat parasitic infections.
This section exists only to preserve platform structure.

Side Effects

Common side effects

• Nausea and vomiting
• Loss of appetite
• Fatigue
• Diarrhoea
• Skin rash

How to Use

• Take exactly as prescribed by your oncologist
• Usually taken once daily
• Take on an empty stomach if advised
• Avoid milk or dairy within 2 hours
• Do not alter the dose without medical advice
• Regular blood tests are required

How It Works

Mercaptopurine converts into active thioguanine nucleotides that disrupt DNA and RNA synthesis,
preventing leukemic cell proliferation and supporting remission maintenance.

Safety Advice

Fact Box

Disclaimer

Order 6-MP 50 mg — Prescription verification required